Safety and Immunogenicity of Two Doses of Quadrivalent Meningococcal Conjugate Vaccine or One Dose of Meningococcal Group C Conjugate Vaccine, both Administered Concomitantly with...

by Francisco Noya, Deirdre McCormack, Donna L Reynolds, Dion Neame, Philipp Oster
Published 2014-01-01

Vaccine Preventability of Meningococcal Clone, Greater Aachen Region, Germany

by Johannes Elias, Leo M. Schouls, Ingrid van de Pol, Wendy C. Keijzers, Diana R. Martin, Anne Glennie, Philipp Oster, Matthias Frosch, Ulrich Vogel, Arie van der Ende
Published 2010-03-01

Safety and immunogenicity of a single dose of a quadrivalent meningococcal conjugate vaccine (MenACYW–D): a multicenter, blind-observer, randomized, phase III clinical trial in the...

by Dong Soo Kim, Min Ja Kim, Sung-Ho Cha, Hwang Min Kim, Jong-Hyun Kim, Kwang Nam Kim, Jin-Soo Lee, Jun Yong Choi, Valérie Bosch Castells, Hee Soo Kim, Joon Bang, Philipp Oster
Published 2016-04-01

Longitudinal study of meningococcal carriage rates in university entrants living in a dormitory in South Korea.

by Heun Choi, Hyuk Min Lee, Woonji Lee, Jun Hyoung Kim, Hye Seong, Jung Ho Kim, Jin Young Ahn, Su Jin Jeong, Nam Su Ku, Joon-Sup Yeom, Kyungwon Lee, Hee Soo Kim, Philipp Oster, Jun Yong Choi
Published 2021-01-01